Colorectal Cancer (CRC) Completed Phase 2 Trials for Erlotinib (DB00530)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00123851	Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer	Treatment	Capecitabine (DB01101) Erlotinib (DB00530) Oxaliplatin (DB00526)
NCT00940316	Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer	Treatment	Erlotinib (DB00530) Irinotecan (DB00762) Panitumumab (DB01269)
NCT03086538	Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy	Treatment	Erlotinib (DB00530) Pemetrexed (DB00642)
NCT01135498	A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Erlotinib (DB00530) Oxaliplatin (DB00526)
NCT00116506	Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Erlotinib (DB00530)